|
|
Other links at Articles > Dermatology |
| 2. |
U.S. Regulator Agrees to Study Botox Rival
|
|
|
French drugs group Ipsen and its U.S. partner Medicis said on Monday the Food and Drug Administration had agreed to evaluate Reloxin for cosmetic use in a potential boost for the would-be Botox competitor. Reuters Health Information
|
| 3. |
Dapsone May Be Glucocorticoid-Sparing in Pemphigus Vulgaris
|
|
|
Findings from a small study indicate that dapsone may be of help in reducing steroid dependence in certain patients with pemphigus vulgaris, researchers report in the January issue of the Archives of Dermatology. Reuters Health Information
|
|
|